These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Evidence for involvement of beta-glucan-binding cell surface lectins in human natural killer cell function.
    Author: Duan X, Ackerly M, Vivier E, Anderson P.
    Journal: Cell Immunol; 1994 Sep; 157(2):393-402. PubMed ID: 8069924.
    Abstract:
    We have studied the effects of yeast cell wall derivatives (zymosan and particulate beta-glucan), on the cytolytic effector function of human natural killer cells. Both zymosan and particulate beta-glucan were found to inhibit the NK-cell-mediated killing of K562, Molt-4, U937, and HL60 tumor cells. Zymosan also inhibited the IL-2-dependent proliferation of NK cells, suggesting that some component of the yeast cell wall delivers a down-modulatory signal affecting multiple NK cell functions. NK cell surface molecules capable of binding both zymosan and Sepharose-immobilized pustulan (linear 1,6-beta-D-glucan, a carbohydrate component of zymosan and particulate beta-glucan) were identified in detergent lysates prepared from surface iodinated NK cells. Our results suggest that NK cells express cell surface beta-glucan-binding lectins that may contribute to NK-cell-mediated natural cytotoxicity.
    [Abstract] [Full Text] [Related] [New Search]